Isosorbide dinitrate recall
Involves only products marketed under the Qualitest label, not products marketed under both the Qualitest and Barr labels, as listed in the June 11 issue of "The Pink Sheet." According to Barr, all but nine bottles were recovered since the termination of the recall instead of the estimated 32 bottles mentioned in the FDA recall notice.
You may also be interested in...
The independent, family-controlled German group has signed a third R&D pact with Danish biotech Gubra to develop poly-agonist peptides for obesity.
Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.
In the month ahead, a key ANDA approval could come for Viatris, while additional competition to Gilead Sciences’ Truvada for PrEP is on the way in the US following Teva and Amneal’s launches.